预测酒精相关癌症患者预后的生物标记物
|
By LabMedica International staff writers Posted on 07 Mar 2018 |
|
图片：用髓过氧化物酶抗体染色的人胃腺癌样本（图片蒙罗氏生命科学公司惠赐）。
摄入酒精被认定为胃癌等癌症的可改变风险因子。摄入的酒精可能降低核糖核酸聚合酶III (POLR3)的水平，造成氧化损伤，进而诱发胃癌。
一份新报告阐明了特定的蛋白质如何与酒精相互作用以及这种相互作用如何影响接受含铂辅助化疗的胃癌患者的生存和反应，这些患者可能仍在饮酒，也可能不在饮酒。
位于合肥的安徽医科大学的科学家分析了77名患者的肿瘤组织样本和69份取自肿瘤区外的组织样本，他们因原发性胃腺癌接受了手术。其中66名患者接受了根除手术，57名患者接受了含铂辅助化疗。77名患者全部接受了平均为期18个月的随访，期间94% (62/66)的患者疾病复发。他们保持无病的平均期限为14个月（无病存活期，DFS），而总体存活期(OS)的中值为20个月。
科研小组发现，转录因子IIB相关因子1 (BRF1)、乳腺癌易感基因1/2 (BRCA1/2)和髓过氧化物酶(MPO)也有助于预测哪些患者将更多得益于含铂辅助化疗。例如，接受化疗患者的DFS延长了两倍或更多，且未发现BRCA1/2或其表达水平很低。无BRCA1或BRCA1表达水平低的患者无病的平均期限为18个月，而高表达组的平均无病期限为9个月。MPO阴性患者也有更佳的预后趋势，尽管统计意义不显著。
研究人员发现，酒精一直对患者产生有害作用。胃癌患者的饮酒习惯如果有危险或有害，会更常出现BRF1表达水平高以及MPO阳性炎性细胞滤过的情况。酗酒者更常出现肿瘤外组织内BRCA1的范围异常。这些研究人员此前的研究发现，乳腺癌和肝癌患者的BRF1 水平与酒精摄入之间也有类似的关联。
该研究的论文发表于2018年1月10日的《美国病理杂志》(The American Journal of Pathology)。联合资深作者Hua Wang博士说：“摄入酒精是已知的胃癌风险因子，中国胃癌的患病程度和致死率很高。我们发现了与DNA修复相关的因子——BRF1、BRCA1/2和MPO对于胃癌患者有很好的预后价值，无论他们有没有饮酒习惯。再者，这些蛋白质也影响着含铂辅助化疗对胃癌患者如何起作用。”
Related Links:
安徽医科大学
一份新报告阐明了特定的蛋白质如何与酒精相互作用以及这种相互作用如何影响接受含铂辅助化疗的胃癌患者的生存和反应，这些患者可能仍在饮酒，也可能不在饮酒。
位于合肥的安徽医科大学的科学家分析了77名患者的肿瘤组织样本和69份取自肿瘤区外的组织样本，他们因原发性胃腺癌接受了手术。其中66名患者接受了根除手术，57名患者接受了含铂辅助化疗。77名患者全部接受了平均为期18个月的随访，期间94% (62/66)的患者疾病复发。他们保持无病的平均期限为14个月（无病存活期，DFS），而总体存活期(OS)的中值为20个月。
科研小组发现，转录因子IIB相关因子1 (BRF1)、乳腺癌易感基因1/2 (BRCA1/2)和髓过氧化物酶(MPO)也有助于预测哪些患者将更多得益于含铂辅助化疗。例如，接受化疗患者的DFS延长了两倍或更多，且未发现BRCA1/2或其表达水平很低。无BRCA1或BRCA1表达水平低的患者无病的平均期限为18个月，而高表达组的平均无病期限为9个月。MPO阴性患者也有更佳的预后趋势，尽管统计意义不显著。
研究人员发现，酒精一直对患者产生有害作用。胃癌患者的饮酒习惯如果有危险或有害，会更常出现BRF1表达水平高以及MPO阳性炎性细胞滤过的情况。酗酒者更常出现肿瘤外组织内BRCA1的范围异常。这些研究人员此前的研究发现，乳腺癌和肝癌患者的BRF1 水平与酒精摄入之间也有类似的关联。
该研究的论文发表于2018年1月10日的《美国病理杂志》(The American Journal of Pathology)。联合资深作者Hua Wang博士说：“摄入酒精是已知的胃癌风险因子，中国胃癌的患病程度和致死率很高。我们发现了与DNA修复相关的因子——BRF1、BRCA1/2和MPO对于胃癌患者有很好的预后价值，无论他们有没有饮酒习惯。再者，这些蛋白质也影响着含铂辅助化疗对胃癌患者如何起作用。”
Related Links:
安徽医科大学
Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Systemic Autoimmune Testing Assay
BioPlex 2200 ANA Screen with MDSS
Latest 临床化学 News
Channels
Clinical Chemistry
view channel
3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more.jpg "Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)")
POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more
Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
The conventional methods for measuring free cortisol, the body's stress hormone, from blood or saliva are quite demanding and require sample processing. The most common method, therefore, involves collecting... Read more
Molecular Diagnostics
view channel
Simple Blood Test Could Enable First Quantitative Assessments for Future Cerebrovascular Disease
Cerebral small vessel disease is a common cause of stroke and cognitive decline, particularly in the elderly. Presently, assessing the risk for cerebral vascular diseases involves using a mix of diagnostic... Read more
New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk
A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more
Hematology
view channel
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more
First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy
Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read moreImmunology
view channel
Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies
Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more
AI Tool Precisely Matches Cancer Drugs to Patients Using Information from Each Tumor Cell
Current strategies for matching cancer patients with specific treatments often depend on bulk sequencing of tumor DNA and RNA, which provides an average profile from all cells within a tumor sample.... Read more
Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment
Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Microbiology
view channel
Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases
GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more
Clinical Decision Support Software a Game-Changer in Antimicrobial Resistance Battle
Antimicrobial resistance (AMR) is a serious global public health concern that claims millions of lives every year. It primarily results from the inappropriate and excessive use of antibiotics, which reduces... Read more
New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
According to the World Health Organization (WHO), an estimated 354 million individuals globally are afflicted with chronic hepatitis B or C. These viruses are the leading causes of liver cirrhosis, liver... Read more
1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
Sepsis contributes to one in every three hospital deaths in the US, and globally, septic shock carries a mortality rate of 30-40%. Diagnosing sepsis early is challenging due to its non-specific symptoms... Read morePathology
view channel.jpg "Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)")
Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization
Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
First of Its Kind Universal Tool to Revolutionize Sample Collection for Diagnostic Tests
The COVID pandemic has dramatically reshaped the perception of diagnostics. Post the pandemic, a groundbreaking device that combines sample collection and processing into a single, easy-to-use disposable... Read more
AI-Powered Digital Imaging System to Revolutionize Cancer Diagnosis
The process of biopsy is important for confirming the presence of cancer. In the conventional histopathology technique, tissue is excised, sliced, stained, mounted on slides, and examined under a microscope... Read more
New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance
Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read moreTechnology
view channel
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read more
DNA Biosensor Enables Early Diagnosis of Cervical Cancer
Molybdenum disulfide (MoS2), recognized for its potential to form two-dimensional nanosheets like graphene, is a material that's increasingly catching the eye of the scientific community.... Read more
Self-Heating Microfluidic Devices Can Detect Diseases in Tiny Blood or Fluid Samples
Microfluidics, which are miniature devices that control the flow of liquids and facilitate chemical reactions, play a key role in disease detection from small samples of blood or other fluids.... Read more
Breakthrough in Diagnostic Technology Could Make On-The-Spot Testing Widely Accessible
Home testing gained significant importance during the COVID-19 pandemic, yet the availability of rapid tests is limited, and most of them can only drive one liquid across the strip, leading to continued... Read moreIndustry
view channel_1.jpg "Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)")
Thermo Fisher and Bio-Techne Enter Into Strategic Distribution Agreement for Europe
Thermo Fisher Scientific (Waltham, MA USA) has entered into a strategic distribution agreement with Bio-Techne Corporation (Minneapolis, MN, USA), resulting in a significant collaboration between two industry... Read more
ECCMID Congress Name Changes to ESCMID Global
Over the last few years, the European Society of Clinical Microbiology and Infectious Diseases (ESCMID, Basel, Switzerland) has evolved remarkably. The society is now stronger and broader than ever before... Read more
